More than 140 years ago, lupus erythematosus (LE) was recognized as a disease entity by clinicians working in the field of dermatology, which had only recently become an independent medical discipline. Soon after cutaneous lupus was first reported, it was realized that, apart from the skin, the disease could involve other organs and thus be systemic in nature. The latter observations were first made by MORITZ KApOSI [1], whose work has attracted renewed attention re cently and who succeeded FERDINAND VON HEBRA to the chair of dermatology at the Medical Faculty in Vienna. The early description of lupus erythematosus in both its cutaneous and systemic manifes tations was thus intimately associated with Vienna and its Medical School. The next phase in the study of lupus was characterized by an in crease in knowledge of the type and extent of organ involvement. The work by OSLER [2], LIBMANN and SACKS [3], and KLEMPERER [4] best represents these advances. The increase in clinical knowledge of LE finally led to DUBOIS' famous monograph [5], which was pub lished at a time of renewed interest in SLE, elicited by the descrip tion by HARGRAVES et al. [6] of the LE-cell phenomenon. A more detailed analysis of this finding revealed that the disease was charac terized by an abnormal immune response, although its pathogenetic implications were still unclear.
Completely updated, revised, and expanded with the most comprehensive and accessible reference on SLE for clinicians and scientists Full-color presentation throughout the book Provides the latest information available on diagnosis and ...
A ready resource for primary care providers managing patients with rheumatic disorders. This concise and up-to-date reference covers the full spectrum of rheumatologic diseases, from simple soft-tissue problems such as...
In this invaluable, practical book, the reader will find introductory chapters regarding general diagnostic and treatment principles, followed by chapters addressing the lupus-specific organ manifestations.
This comprehensive book is focused on the instruments and outcome measures utilized in the assessment of SLE.
The scope of this contributed volume is to provide an overview of the latest translational research in the field of lupus pathogenesis, with particular emphasis on how these discoveries progress in parallel with therapeutic drug development ...
The book includes various interesting chapters: Chapter One: An illustrated overview of the prevalence and clinical symptoms of systemic lupus erythematosus; Chapter Two: Pathophysiology of systemic lupus erythematosus; Chapter Three: MBL ...
Linnik MD, Hu JZ, Heibrunn KR, Strand V, Hurley FL, Joh T. LJP 394 Investigator Consortium. ... Neutrophil chemotaxis and serum chemotactic activity in systemic lupus erythematosus. Scand J Rheumatol 1978;7:69-74. 34. Yu CL ...
Benjamin. F. Chong. and. Victoria. P. Werth. Introduction, 719 Photoprotection, 719 Topical Medications, 720 Intralesional Therapy, 721 Antimalarials, 721 Oral/Intravenous Corticosteroids, 721 Mycophenolate Mofetil, 721 Methotrexate, ...
This new book is devoted to leading-edge research developments in lupus which is a condition of chronic inflammation caused by an autoimmune disease.
SLE can potentially influence nearly all of the body's organ systems. In this book, Chapter One reviews, Raynaud's phenomenon (RP), one of the nonspecific skin changes that occur in SLE.